Ga. Comp. R. & Regs. R. 480-34-.07 - Hallucinogens
(1) This rule was
adopted to protect the health, safety, and welfare of the public. This rule
places additional newly identified compounds, including any material, compound,
mixture, or preparation which contains any quantity of the following
substances, their salts, isomers (whether optical, position, or geometrics),
and salts of isomers under Schedule I of the Georgia Controlled Substances Act,
Section
16-13-25(3)as
follows:
(BBBB) Methoxyphencyclidine
(MeO-PCP)
(CCCC)
4-hydroxy-N-methyl-N-isopropyltryptamine (4-OH-MiPT)
(DDDD)
N,[ALPHA]-dimethyl-5-benzofuranethanamine (5-MAPB)
(EEEE)
1-pentyl-N-(phenylmethyl)-1H-indole-3-carboxamide (SDB-006)
(FFFF) methyl
(S)-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate
(MDMB-CHMICA)
(2) This
rule is based on the following findings of the Board:
(a) that hallucinogens have an extremely high
potential for abuse;
(b) that
scientific evidence and scientific knowledge of the pharmacological effects of
these compounds demonstrate that the public is at extreme risk if they are not
regulated as controlled substances;
(c) that the pattern of abuse of these
compounds and the scope and significance of that abuse support
regulation;
(d) that there exists
an imminent peril to the public health and welfare with regard to the abuse of
these compounds;
(e) that these
compounds have the same risk to the public health of citizens of the State of
Georgia as other substances already contained in Schedule I under the
Controlled Substances Act; and
(f)
that these compounds have no known precursor already scheduled under the
Act.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.